Neutrolis Inc
Biotechnology
1 Broadway
14 employees
- Employees
- 14
- Contacts
- 3
- Emails
- 3
- Phones
- 2
Neutrolis Inc Overview
- Headquarters
- 1 Broadway
- Website
- neutrolis.com
- Industry
- Biotechnology
- Employees
- 14
- Founded
- 2017
- Funding
- 23.1M
Keywords
About Neutrolis Inc
Neutrolis, Inc. is a biotechnology company developing therapeutics that target neutrophils, the most abundant immune cell in our body. Neutrolis’ lead program targets Neutrophil Extracellular Traps (NETs). NETs are a fundamental arm of the innate immune system and play an important role in chronic and acute diseases. Based in Cambridge, MA, Neutrolis was founded by two of the earliest and most cited leaders in the NETs field and supported by seasoned business leaders.
Neutrolis Inc Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 2
- 50.0% coverage
Neutrolis Inc Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Michael Fleming | Chief Business & Strategy Officer | Burlingame, California, United States |
Email
Phone
|
| John Sundy | Chief Medical Officer and Head of R&D |
View
|
|
| Ralph Lambalot | Executive Leader Driving Innovation | Cambridge, Massachusetts, United States |
Email
Phone
|
| David Tischler | Biotech Executive - Entrepreneur | San Francisco, California, United States |
Email
|
Employees by Management Level
Executive
2 profiles
Individual contributor
2 profiles
Compare Similar Companies to Neutrolis Inc
Moderna
Biotechnology Research
Manus
Biotechnology Research
Calbiotech, Inc
Medical Equipment Manufacturing
Morningside
Venture Capital And Private Equity Principals
Siro Diagnostics
Biotechnology Research
KdT Ventures
Venture Capital And Private Equity Principals
LatchBio
Biotechnology Research
Apertura Gene Therapy
Biotechnology Research
Artus Therapeutics
Pharmaceutical Manufacturing
TargetRNA Inc.
Pharmaceutical Manufacturing